Company overview
Panome Bio is a multi-omics contract research organization offering next-generation metabolomics, discovery proteomics, transcriptomics, exposomics, and integrated multi-omics analysis for bioprocessing optimization and biomarker discovery. Their LC/MS platform with MassID™ engine detects up to 4x more compounds with superior reproducibility and no missing values compared to legacy methods. Services support applications in cultivated meat, neurodegeneration, cancer, metabolic disease, and environmental exposure profiling, delivering results in 4-6 weeks.
Panomebio is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include multi-omics, metabolomics, proteomics, exposomics, bioprocessing.
Structured facts
- Website
- https://panomebio.com
- Markets served
- United States & Americas
- Keywords
- multi-omics, metabolomics, proteomics, exposomics, bioprocessing
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What omics services does Panome Bio provide?
- Panome Bio offers next-generation metabolomics, discovery proteomics, transcriptomics, exposomics (Discovery and Targeted), and integrated multi-omics analysis using LC/MS and AI-powered bioinformatics.
- What are the advantages of Panome Bio's metabolomics platform?
- Their platform detects 3.86x more compounds (3,003 vs. 777 per sample), identifies nearly 2x more metabolic pathways, achieves 2.4x better reproducibility (4.3% median CV), and produces complete data matrices with 0% missing values.
- What are the turnaround times and applications?
- Results are delivered in 4-6 weeks, supporting bioprocessing optimization (e.g., cultivated meat media analysis), biomarker discovery, and research in neurodegeneration, cancer, metabolic disease, exposomics, and product safety.
Related editorial coverage
- INTERPHEX 2026: Phillips Medisize's Embedded Sensing Tech
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
